Kuros Biosciences raised €6.3M in a Growth/Late round in Sep 2022. The company is based in Zurich, Switzerland. Investors in the round: Optiverder B.V, The Netherlands and Pegasus Global Opportunity Fund . Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
